
What Is Aspergillus Fumigatus? Deadly Fungus Spreading In US That ‘Eats You From Inside Out'
Last Updated:
Aspergillus Fumigatus is now being detected with increasing frequency in Florida, Louisiana, Texas, Georgia and California.
Health experts are raising concerns over the rapid spread of a deadly airborne fungus, Aspergillus fumigatus, across parts of the United States. The pathogen, which causes a potentially fatal lung infection called aspergillosis, poses a heightened threat as rising temperatures create ideal conditions for its growth, experts warned.
The fungus is now being detected with increasing frequency in Florida, Louisiana, Texas, Georgia and California- states where warm and humid environments allow it to thrive- Daily Mail reported. The World Health Organization labeled Aspergillus fumigatus a 'critical priority" pathogen, citing its growing resistance to treatment and high mortality rates.
What Is Aspergillus Fumigatus And Its Symptoms?
Once inhaled, the fungus can lead to serious respiratory infections, particularly in people with weakened immune systems or pre-existing lung conditions. Symptoms can escalate rapidly, potentially resulting in organ failure or death, especially among cancer patients, transplant recipients and those recovering from severe influenza. Individuals undergoing chemotherapy, long-term corticosteroid therapy or AIDS patients are considered especially vulnerable. The fungus is commonly found in soil, compost piles and damp environments, where it can survive temperatures as high as 120°F.
The US Centers for Disease Control and Prevention (CDC) issued precautionary advice to reduce the risk of exposure to Aspergillus fumigatus. While these measures cannot guarantee full protection, they are recommended- especially for those with weakened immune systems or existing respiratory conditions, the health body said.
The CDC advises people to avoid dusty areas such as construction sites. If exposure is unavoidable, wearing an N95 mask is recommended. During outdoor activities like gardening, individuals should wear long-sleeved clothing, full-length pants and closed-toe shoes and ideally avoid direct contact with soil or compost. In case of any cuts or abrasions, the area should be washed immediately with soap and water to reduce the risk of infection.
About the Author
Mallika Soni
When not reading, this ex-literature student can be found searching for an answer to the question, "What is the purpose of journalism in society?"
Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated!
First Published:
June 18, 2025, 22:22 IST
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
US measles count now tops 1,200 cases, and Iowa announces an outbreak
The U.S. logged fewer than 20 measles cases this week, though Iowa announced the state's first outbreak Thursday and Georgia confirmed its second Wednesday. There have been 1,214 confirmed measles cases this year, the Centers for Disease Control and Prevention said Friday. Health officials in Texas, where the nation's biggest outbreak raged during the late winter and spring, confirmed six cases in the last week. There are three other major outbreaks in North America. The longest, in Ontario, Canada, has resulted in 2,179 cases from mid-October through June 17. The province logged its first death June 5 in a baby who got congenital measles but also had other preexisting conditions. Another outbreak in Alberta, Canada, has sickened 996 as of Thursday. And the Mexican state of Chihuahua had 2,335 measles cases and four deaths as of Friday, according to data from the state health ministry. Other U.S. states with active outbreaks - which the CDC defines as three or more related cases - include Arizona, Colorado, Illinois, Kansas, Montana, New Mexico, North Dakota and Oklahoma. In the U.S., two elementary school-aged children in the epicenter in West Texas and an adult in New Mexico have died of measles this year. All were unvaccinated. Measles is caused by a highly contagious virus that's airborne and spreads easily when an infected person breathes, sneezes or coughs. It is preventable through vaccines and has been considered eliminated from the U.S. since 2000. How many measles cases are there in Texas? There are a total of 750 cases across 35 counties, most of them in West Texas, state health officials said Tuesday. Throughout the outbreak, 97 people have been hospitalized. State health officials estimated less than 1% of cases - fewer than 10 - are actively infectious. Fifty-five percent of Texas' cases are in Gaines County, where the virus started spreading in a close-knit, undervaccinated Mennonite community. The county has had 413 cases since late January - just under 2% of its residents. The April 3 death in Texas was an 8-year-old child, according to Health Secretary Robert F. Kennedy Jr. Local health officials said the child did not have underlying health conditions and died of "what the child's doctor described as measles pulmonary failure." A unvaccinated child with no underlying conditions died of measles in Texas in late February; Kennedy said the child was 6. How many measles cases are there in New Mexico? New Mexico held steady Friday with a total of 81 cases. Seven people have been hospitalized since the outbreak started. Most of the state's cases are in Lea County. Sandoval County near Albuquerque has six cases, Eddy County has three, Doña Ana County has two. Chaves, Curry and San Juan counties have one each. An unvaccinated adult died of measles-related illness March 6. The person did not seek medical care. How many cases are there in Oklahoma? Oklahoma added one case Friday for a total of 17 confirmed and three probable cases. The state health department is not releasing which counties have cases. How many cases are there in Arizona? Arizona has four cases in Navajo County. They are linked to a single source, the county health department said June 9. All four were unvaccinated and had a history of recent international travel. How many cases are there in Colorado? Colorado has seen a total of 16 measles cases in 2025, which includes one outbreak of 10 related cases. The outbreak is linked to a Turkish Airlines flight that landed at Denver International Airport in mid-May. Four of the people were on the flight with the first case - an out-of-state traveler not included in the state count - while five got measles from exposure in the airport and one elsewhere. Health officials are also tracking an unrelated case in a Boulder County resident. The person was fully vaccinated but had "recently traveled to Europe, where there are a large number of measles cases," the state health department said. Other counties that have seen measles this year include Archuleta and Pueblo. How many cases are there in Georgia? Georgia has an outbreak of three cases in metro Atlanta, with the most recent infection confirmed Wednesday. The state has confirmed six total cases in 2025. The remaining three are part of an unrelated outbreak from January. How many cases are there in Illinois? Illinois health officials confirmed a four-case outbreak on May 5 in the far southern part of the state. It grew to eight cases as of June 6, but no new cases were reported in the following weeks, according to the Illinois Department of Public Health. The state's other two cases so far this year were in Cook County, and are unrelated to the southern Illinois outbreak. How many cases are there in Iowa? Iowa has had six total measles cases in 2025. Four are part of an outbreak in eastern Johnson County, among members of the same household. County health officials said the people are isolating at home, so they don't expect additional spread. How many cases are there in Kansas? Kansas has a total of 79 cases across 11 counties in the southwestern part of the state, with three hospitalizations. All but three of the cases are connected, and most are in Gray County. How many cases are there in Montana? Montana had 22 measles cases as of Friday. Fourteen were in Gallatin County, which is where the first cases showed up - Montana's first in 35 years. Flathead and Yellowstone counties had two cases each, and Hill County had four cases. There are outbreaks in neighboring North Dakota and the Canadian provinces of Alberta, British Columbia and Saskatchewan. How many cases are there in North Dakota? North Dakota, which hadn't seen measles since 2011, was up to 34 cases as of June 6, but has held steady since. Two of the people have been hospitalized. All of the people with confirmed cases were not vaccinated. There were 16 cases in Williams County in western North Dakota on the Montana border. On the eastern side of the state, there were 10 cases in Grand Forks County and seven cases in Cass County. Burke County, in northwest North Dakota on the border of Saskatchewan, Canada, had one case. Where else is measles showing up in the U.S.? Measles cases also have been reported this year in Alaska, Arkansas, California, District of Columbia, Florida, Hawaii, Indiana, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, Rhode Island, South Dakota, Vermont, Virginia and Washington. Health officials declared earlier outbreaks in Indiana, Michigan, Ohio and Pennsylvania over after six weeks of no new cases. Tennessee's outbreak also appears to be over. Cases and outbreaks in the U.S. are frequently traced to someone who caught the disease abroad. The CDC said in May that more than twice as many measles have come from outside of the U.S. compared to May of last year. Most of those are in unvaccinated Americans returning home. In 2019, the U.S. saw 1,274 cases and almost lost its status of having eliminated measles. What do you need to know about the MMR vaccine? The best way to avoid measles is to get the measles, mumps and rubella vaccine. The first shot is recommended for children between 12 and 15 months old and the second between 4 and 6 years old. Getting another MMR shot as an adult is harmless if there are concerns about waning immunity, the CDC says. People who have documentation of receiving a live measles vaccine in the 1960s don't need to be revaccinated, but people who were immunized before 1968 with an ineffective vaccine made from "killed" virus should be revaccinated with at least one dose, the agency said. People who have documentation that they had measles are immune and those born before 1957 generally don't need the shots because so many children got measles back then that they have "presumptive immunity." Measles has a harder time spreading through communities with high vaccination rates - above 95% - due to "herd immunity." But childhood vaccination rates have declined nationwide since the pandemic and more parents are claiming religious or personal conscience waivers to exempt their kids from required shots. What are the symptoms of measles? Measles first infects the respiratory tract, then spreads throughout the body, causing a high fever, runny nose, cough, red, watery eyes and a rash. The rash generally appears three to five days after the first symptoms, beginning as flat red spots on the face and then spreading downward to the neck, trunk, arms, legs and feet. When the rash appears, the fever may spike over 104 degrees Fahrenheit, according to the CDC. Most kids will recover from measles, but infection can lead to dangerous complications such as pneumonia, blindness, brain swelling and death. How can you treat measles? There's no specific treatment for measles, so doctors generally try to alleviate symptoms, prevent complications and keep patients comfortable.


Time of India
4 hours ago
- Time of India
Trump aid cuts deal a blow to HIV prevention in Africa
Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump 's administration cut access for at-risk groups like gay men and injecting drug users to medication that prevents infection. Cherem admits he should have been more careful about practicing safe sex but had become accustomed to using the U.S.-supplied pharmaceutical. The drug - known as Pre-Exposure Prophylaxis, or PrEP - is typically taken daily as a tablet and can reduce the risk of contracting HIV through sex by 99%. "I blame myself... Taking care of myself is my first duty as a person," Cherem said at his gym in Awka, the capital of Nigeria's southeastern state of Anambra. "I equally blame the Trump administration because, you know, these things were available, and then, without prior notice, these things were cut off." Trump ordered a 90-day pause on foreign aid after taking office in January and halted grants by the U.S. Agency for International Development (USAID). The agency was responsible for implementing the bulk of the assistance under the President's Emergency Plan for AIDS Relief ( PEPFAR ), the world's leading HIV/AIDS initiative. Sub-Saharan Africa remains the epicenter of the AIDS pandemic. Trump's cuts have restricted the availability of drugs that millions of Africans have taken to prevent infection - particularly vulnerable communities such as gay men and sex workers - as aid groups and public health systems in Africa strove to roll back the disease. The number of initiations, or people who have taken at least one dose of the drug, rose in Africa from fewer than 700 in 2016 to more than 6 million by late 2024, according to PrEPWatch, a global tracker. More than 90% of new initiations last year were financed by PEPFAR, using cheap generic versions of the drug. Sub-Saharan Africa had 390,000 AIDS-related deaths in 2023, or 62% of the global total, according to UNAIDS, the United Nations AIDS agency. However, progress has been made: that death toll was down by 56% from 2010, according to the World Health Organization. Now, some of those who've lost access to the preventative medication because of U.S. cutbacks are already testing positive, according to 10 patients, health officials and activists. Restrictions on PrEP have coincided with dwindling supplies of more widely used HIV prevention tools like condoms and lubricants "because of the US funding cuts", according to a UNAIDS fact sheet from May. The combination is creating what nine activists and three medical experts described as a major threat to prevention across the continent. "I just see this as incredibly short-sighted because we were on a winning path," said Linda-Gail Bekker, an HIV expert at the University of Cape Town. She said that many African governments did not have the resources to spend on PrEP drugs on top of treatment for HIV infections, risking a worsening of the pandemic. "It's as predictable as if you take your eye off a smouldering bushfire and the wind is blowing: a bushfire will come back." Trump has said that the United States pays disproportionately for foreign aid and he wants other countries to shoulder more of the burden, as he seeks to reduce U.S. government spending across the board. The U.S. disbursed $65 billion in foreign assistance last year, nearly half of it via USAID, according to government data. "It's a question of who has primary responsibility for the health needs of citizens of other countries, and it's their own governments," said Max Primorac , a former senior USAID official who is now senior research fellow at The Heritage Foundation's Margaret Thatcher Center for Freedom. "We all know, and this is a bipartisan issue, that aid dependency doesn't help these people - that the best solution is for these countries to be able to take over the responsibility of these programs." A RISE IN CASES UNAIDS says the permanent discontinuation of PEPFAR-supported prevention and treatment programs could lead to an additional 2,300 new HIV cases globally per day. There were 3,500 new cases per day in 2023. Reuters spoke to 23 health workers, PrEP users and activists, nearly all of whom said that the increase in HIV infections since the funding cuts was impossible to quantify because many organisations working with vulnerable populations have been defunded. A State Department waiver issued on February 1 allowed some PEPFAR activities to restart, but only covered HIV prevention for mother-to-child transmission. That means PEPFAR-financed PrEP is no longer available for gay and bisexual men, sex workers and injecting drug users who are especially exposed to the virus. Many African governments had specifically targeted these groups in their PrEP programs. A spokesperson for the State Department, which oversees USAID and the PEPFAR program, told Reuters it "continues to support lifesaving HIV testing, care and treatment, and prevention of mother to child transmission services approved by the Secretary of State." "All other PEPFAR-funded services are being reviewed for assessment of programmatic efficiencies and consistency with United States foreign policy," the spokesperson said. The spokesperson did not directly respond to a question about why the waiver had excluded vulnerable groups from PrEP distribution. In East and Southern Africa, the sub-region that accounts for more than half of all people living with HIV, the U.S. had been funding nearly 45% of HIV prevention programming, UNAIDS said in March. Some countries like Malawi, Zimbabwe and Mozambique were almost entirely dependent on PEPFAR for their HIV prevention programs, the agency said. In some wealthier nations, like South Africa and Kenya, PEPFAR represented less than 25% of spending on HIV prevention. Russell Vought , the director of the U.S. Office of Management and Budget, told a Congressional committee on June 4 that, due to high U.S. debt levels, Africa needed to shoulder more of the burden in fighting AIDS. Asked specifically about restrictions on HIV prevention programs, Vought said: "We believe that many of these nonprofits are not geared toward the viewpoints of the administration." His office did not respond to a request for further details. 'I PRAY TRUMP CHANGES HIS POLICY' Reuters spoke to four PrEP users in Nigeria, all gay or bisexual men, who have tested positive for HIV since January when they stopped being able to obtain more pills, after practicing unsafe sex. Hearty Empowerment and Rights (HER) Initiative, a community-based organisation in southeastern Nigeria, worked with other groups that provide HIV/AIDS services to confirm the men's diagnosis and help secure treatment for them, said executive director Festus Alex Chinaza. In Asaba, the capital of Nigeria's Delta state, Echezona, a 30-year-old gay man who took PrEP pills daily for more than three years, is struggling to come to terms with his HIV-positive test result, which he received in early May. He regrets that he had unprotected sex. "I just pray and wish that Trump actually changes his policy and everything comes back to normal so that the spread and transmission of the virus would be reduced," said Echezona, who asked to be identified only by his first name for fear of stigma. Like the other three men, he described being told by staff at community-based clinics that PrEP was only available to pregnant and lactating women, in line with the Trump administration guidelines. Nigeria has an adult HIV prevalence rate of 1.3% and an estimated 2 million people living with HIV, the fourth-highest total globally, according to UNAIDS. But for so-called key populations, the rates are much higher: 25% for men who have sex with men, according to a survey completed in 2021. The Nigerian health ministry did not respond to a request for comment on the effects of the Trump administration's cuts to HIV prevention services. South Africa - which has an estimated 7.7 million people living with HIV, according to UNAIDS, the highest number in the world - pays for its own PrEP pills. But some clinics where so-called key populations obtained them relied on PEPFAR grants and have been forced to close in recent months. PrEP is also available for free at public health centers, but gay men and sex workers often avoid such facilities, fearing discrimination and harassment, nine activists said. Francois Venter, executive director of the Ezintsha medical research center at the University of the Witwatersrand in Johannesburg, said PrEP distribution from public sector clinics in the city had shown almost no increase since the Trump cuts. Foster Mohale, spokesperson for South Africa's health ministry, said the ministry was "not aware" of reports that key populations were avoiding health facilities due to stigma. "We have sensitized health officials across the country to create (a) conducive environment for all healthcare seekers/clients to access the service without feeling judged or discriminated against," he said. (Reporting and writing by Robbie Corey-BouletAdditional reporting by Seun Sanni in Awka, Nigeria, Nellie Peyton in Johannesburg, Amindeh Blaise Atabong in Yaounde, Ange Adihe Kasongo in Kinshasa, Maxwell Akalaare Adombila in Accra and Jennifer Rigby in London. Editing by Daniel Flynn)


Time of India
9 hours ago
- Time of India
A shot of hope
New HIV medicine is powerful – but can everyone afford it? A new medicine called lenacapavir has just been approved in the US to help stop people from getting HIV, the virus that causes AIDS. That's big news! Even though fewer people are getting HIV today than in the 1990s, around 13 lakh (1.3 million) people still get infected every year around the world. Lenacapavir is special because you only need two shots a year – not a pill every day like older medicines. That's great for people who forget daily pills or feel embarrassed taking them. And it's almost 100% effective at stopping HIV in adults and teens. But there's a big problem: the cost. In the US, it sells for over ₹23 lakh a year! Even rich countries find that hard to afford. The company that makes it, Gilead, is working with more than 100 poorer countries to help them make cheaper versions. Still, many African countries where HIV is most common may struggle to get it to the people who need it most. Scientists have been trying to create a proper HIV vaccine for decades, but HIV keeps mutating – changing too fast for one shot to work. New mRNA vaccines (like the ones used for Covid) are being tested, but funding cuts in the US have slowed down this research. That's why lenacapavir gives us hope. But hope only works if everyone, everywhere, can afford it. Facebook Twitter Linkedin Email Disclaimer Views expressed above are the author's own.